2BA Results of the TEAM (tamoxifen exemestane adjuvant multinational) prospective randomized phase III trial in hormone sensitive postmenopausal early breast cancer

Authors :: D.W. Rea
J.M. Vannetzel
J.W.R. Nortier
Stephen E. Jones
Robert Paridaens
J. Smeets
Carine Seynaeve
C.J.H. van de Velde
Annette Hasenburg
C. Markopoulos
Source :: European Journal of Cancer Supplements. 7:1
Publication Year :: 2009
Publisher :: Elsevier BV, 2009.

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
business.industry
medicine.medical_treatment
Hormone-sensitive
chemistry.chemical_compound
Exemestane
chemistry
Internal medicine
medicine
business
Adjuvant
Tamoxifen
Early breast cancer
medicine.drug

Full Text Access

Tools